205 related articles for article (PubMed ID: 15462407)
1. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
[TBL] [Abstract][Full Text] [Related]
2. FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma.
Zettinig G; Leitha T; Niederle B; Kaserer K; Becherer A; Kletter K; Dudczak R
Clin Nucl Med; 2001 Jul; 26(7):599-601. PubMed ID: 11416738
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
4. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
[TBL] [Abstract][Full Text] [Related]
5.
Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma.
Katagiri M; Suzuki S; Sadahiro S; Kubouchi K; Ohmura T; Tsumura O; Akatsuka S
Clin Nucl Med; 1988 Apr; 13(4):276-9. PubMed ID: 2836118
[TBL] [Abstract][Full Text] [Related]
7. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule.
Cirillo RL; Pozderac RV; Caniano DA; Falko JM
Clin Nucl Med; 1998 Jun; 23(6):345-9. PubMed ID: 9619317
[TBL] [Abstract][Full Text] [Related]
8. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
Ozdemir D; Cuhaci FN; Ozdemir E; Aydin C; Ersoy R; Turkolmez S; Cakir B
Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
[TBL] [Abstract][Full Text] [Related]
9. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
Khammash NF; Halkar RK; Abdel-Dayem HM
Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
[TBL] [Abstract][Full Text] [Related]
10. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
Campbell CM; Khafagi FA
Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
[TBL] [Abstract][Full Text] [Related]
11. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
[TBL] [Abstract][Full Text] [Related]
12. "Insular" carcinoma of thyroid. A subset of anaplastic thyroid malignancy with a less aggressive clinical course.
Bal C; Padhy AK; Panda S; Kumar L; Basu AK
Clin Nucl Med; 1993 Dec; 18(12):1056-8. PubMed ID: 8293626
[TBL] [Abstract][Full Text] [Related]
13. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
15. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules.
Mezosi E; Bajnok L; Gyory F; Varga J; Sztojka I; Szabo J; Galuska L; Leovey A; Kakuk G; Nagy E
Eur J Nucl Med; 1999 Aug; 26(8):798-803. PubMed ID: 10436190
[TBL] [Abstract][Full Text] [Related]
16. Metastatic thyroid cancer visualized on technetium pertechnetate and iodine-131 scintigraphy.
Verma N; Singh-Wadhwa S; Arvela OM
Clin Nucl Med; 2002 Aug; 27(8):610. PubMed ID: 12170017
[No Abstract] [Full Text] [Related]
17. Clinical significance of extra-thyroid
Long B; Yao LF; Chen SC; Shui J; Ye XM; Yi HQ; Lou C
J Int Med Res; 2021 May; 49(5):3000605211012667. PubMed ID: 34024177
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
Lamberigts G; De Roo M; Devos P; Burie D
Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
[TBL] [Abstract][Full Text] [Related]
19. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
